Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Gemini Therapeutics, Inc. /DE | 10%+ Owner | Common Stock | 5M | $338M | $67.65 | Oct 26, 2022 | Holding of BML Investment Partners, L.P. |
ASTROTECH Corp | 10%+ Owner | Common Stock | 6.61M | $55.1M | $8.34 | Dec 2, 2022 | Holding of BML Investment Partners, L.P.(1) |
ASTROTECH Corp | 10%+ Owner | Common Stock | 6.35M | $52.9M | $8.34 | Nov 18, 2022 | Holding of BML Investment Partners, L.P. |
IMARA Inc. | 10%+ Owner | Common Stock | 1.77M | $26.8M | $15.14 | Jan 4, 2023 | Holding of BML Investment Partners, L.P. |
Aclaris Therapeutics, Inc. | 10%+ Owner | Common Stock | 14.3M | $17.7M | $1.24 | Aug 5, 2024 | Holding of BML Investment Partners, L.P |
Gemini Therapeutics, Inc. /DE | 10%+ Owner | Common Stock | 248K | $16.7M | $67.65 | Oct 26, 2022 | Direct |
Adverum Biotechnologies, Inc. | 10%+ Owner | Common Stock | 2.27M | $16.2M | $7.15 | Jul 30, 2024 | Holding of BML Investment Partners, L.P. |
Cyteir Therapeutics, Inc. | 10%+ Owner | Common Stock, par value $0.001 per share | 3.65M | $10.8M | $2.95 | Mar 20, 2024 | Holding of BML Investment Partners, L.P |
AN2 Therapeutics, Inc. | 10%+ Owner | Common Stock | 5.75M | $5.98M | $1.04 | Aug 14, 2024 | Holding of BML Investment Partners, L.P. |
Satsuma Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 6.44M | $5.86M | $0.91 | Nov 21, 2022 | Holding of BML Investment Partners, L.P. |
Reneo Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 2.94M | $4.16M | $1.41 | Aug 14, 2024 | Holding of BML Investment Partners, L.P. |
IMARA Inc. | 10%+ Owner | Common Stock | 230K | $3.48M | $15.14 | Jan 3, 2023 | Direct |
ASTROTECH Corp | 10%+ Owner | Common Stock | 350K | $2.92M | $8.34 | Dec 2, 2022 | Direct |
Metacrine, Inc. | 10%+ Owner | Common Stock | 6.16M | $2.9M | $0.47 | Dec 21, 2022 | Holding of BML Investment Partners, L.P. |
Reneo Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 1.02M | $1.44M | $1.41 | Aug 13, 2024 | Direct |
Cyteir Therapeutics, Inc. | 10%+ Owner | Common Stock, par value $0.001 per share | 335K | $988K | $2.95 | Mar 20, 2024 | Direct |
Talis Biomedical Corp | 10%+ Owner | Common Stock | 204K | $889K | $4.37 | Aug 14, 2024 | Holding of BML Investment Partners, L.P. |
RETRACTABLE TECHNOLOGIES INC | 10%+ Owner | Common Stock | 689K | $847K | $1.23 | Dec 29, 2022 | Holding of BML Investment Partners, L.P. |
Adverum Biotechnologies, Inc. | 10%+ Owner | Common Stock | 105K | $749K | $7.15 | Jul 30, 2024 | Direct |
Tectonic Therapeutic, Inc. | Former 10% owner of AVROBIO | Common Stock | 400K | $520K | $1.30 | Jun 20, 2024 | Holding of BML Investment Partners, L.P, |
RETRACTABLE TECHNOLOGIES INC | 10%+ Owner | Common Stock | 388K | $477K | $1.23 | Dec 29, 2022 | Direct |
Metacrine, Inc. | 10%+ Owner | Common Stock | 600K | $282K | $0.47 | Dec 19, 2022 | Direct |
Satsuma Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 150K | $137K | $0.91 | Nov 21, 2022 | Direct |
Tectonic Therapeutic, Inc. | Former 10% owner of AVROBIO | Common Stock | 33.3K | $43.3K | $1.30 | Jun 20, 2024 | Direct |
RETRACTABLE TECHNOLOGIES INC | 10%+ Owner | Put Option (obligation to buy) | 0 | Nov 28, 2022 | Holding of BML Investment Partners, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TLIS | Talis Biomedical Corp | Aug 14, 2024 | 0 | $0 | 3 | Aug 14, 2024 | 10%+ Owner |
ANTX | AN2 Therapeutics, Inc. | Aug 14, 2024 | 1 | $1.56M | 4 | Aug 14, 2024 | 10%+ Owner |
RPHM | Reneo Pharmaceuticals, Inc. | Aug 13, 2024 | 2 | $381K | 4 | Aug 14, 2024 | 10%+ Owner |
ANTX | AN2 Therapeutics, Inc. | Aug 9, 2024 | 0 | $0 | 3 | Aug 12, 2024 | 10%+ Owner |
ACRS | Aclaris Therapeutics, Inc. | Aug 2, 2024 | 2 | $473K | 4 | Aug 5, 2024 | 10%+ Owner |
ADVM | Adverum Biotechnologies, Inc. | Jul 30, 2024 | 1 | $613K | 4 | Jul 31, 2024 | 10%+ Owner |
ACRS | Aclaris Therapeutics, Inc. | Jul 30, 2024 | 2 | $359K | 4 | Jul 31, 2024 | 10%+ Owner |
ACRS | Aclaris Therapeutics, Inc. | Jul 18, 2024 | 3 | $202K | 4 | Jul 22, 2024 | 10%+ Owner |
ADVM | Adverum Biotechnologies, Inc. | Jul 18, 2024 | 2 | $1.79M | 4 | Jul 18, 2024 | 10%+ Owner |
ADVM | Adverum Biotechnologies, Inc. | Jul 17, 2024 | 0 | $0 | 3 | Jul 18, 2024 | 10%+ Owner |
ACRS | Aclaris Therapeutics, Inc. | Jul 2, 2024 | 3 | $406K | 4 | Jul 5, 2024 | 10%+ Owner |
ACRS | Aclaris Therapeutics, Inc. | Jun 27, 2024 | 4 | $1.74M | 4 | Jul 1, 2024 | 10%+ Owner |
TECX | Tectonic Therapeutic, Inc. | Jun 20, 2024 | 2 | $0 | 4 | Jun 25, 2024 | Former 10% owner of AVROBIO |
ACRS | Aclaris Therapeutics, Inc. | Jun 14, 2024 | 3 | $628K | 4 | Jun 18, 2024 | 10%+ Owner |
ACRS | Aclaris Therapeutics, Inc. | Jun 11, 2024 | 4 | $1.78M | 4 | Jun 13, 2024 | 10%+ Owner |
RPHM | Reneo Pharmaceuticals, Inc. | May 14, 2024 | 2 | $640K | 4 | May 16, 2024 | 10%+ Owner |
RPHM | Reneo Pharmaceuticals, Inc. | May 14, 2024 | 0 | $0 | 3 | May 16, 2024 | 10%+ Owner |
AVRO | AVROBIO, Inc. | May 13, 2024 | 3 | $971K | 4 | May 15, 2024 | 10%+ Owner |
AVRO | AVROBIO, Inc. | May 13, 2024 | 0 | $0 | 3/A | May 15, 2024 | 10%+ Owner |
AVRO | AVROBIO, Inc. | May 13, 2024 | 0 | $0 | 3 | May 15, 2024 | 10%+ Owner |
CYT | Cyteir Therapeutics, Inc. | Mar 20, 2024 | 1 | $503K | 4 | Mar 25, 2024 | 10%+ Owner |
CYT | Cyteir Therapeutics, Inc. | Mar 19, 2024 | 1 | $342K | 4 | Mar 19, 2024 | 10%+ Owner |
CYT | Cyteir Therapeutics, Inc. | Mar 15, 2024 | 0 | $0 | 3 | Mar 19, 2024 | 10%+ Owner |
ACRS | Aclaris Therapeutics, Inc. | Feb 7, 2024 | 0 | $0 | 3 | Feb 8, 2024 | 10%+ Owner |
ELVN | IMARA Inc. | Jan 3, 2023 | 1 | -$5M | 4/A | Jan 5, 2023 | 10%+ Owner |
ELVN | IMARA Inc. | Dec 30, 2022 | 1 | -$80.8K | 4 | Dec 30, 2022 | 10%+ Owner |
RVP | RETRACTABLE TECHNOLOGIES INC | Dec 29, 2022 | 1 | -$4.8M | 4 | Dec 29, 2022 | 10%+ Owner |
ELVN | IMARA Inc. | Dec 28, 2022 | 2 | -$80.8K | 4 | Dec 29, 2022 | 10%+ Owner |
ELVN | IMARA Inc. | Dec 22, 2022 | 2 | -$203K | 4 | Dec 27, 2022 | 10%+ Owner |
MTCR | Metacrine, Inc. | Dec 19, 2022 | 3 | $108K | 4 | Dec 21, 2022 | 10%+ Owner |
ASTC | ASTROTECH Corp | Dec 2, 2022 | 1 | $65.6K | 4 | Dec 2, 2022 | 10%+ Owner |
RVP | RETRACTABLE TECHNOLOGIES INC | Nov 28, 2022 | 2 | -$506K | 4 | Nov 30, 2022 | 10%+ Owner |
ASTC | ASTROTECH Corp | Nov 23, 2022 | 1 | $24.7K | 4 | Nov 25, 2022 | 10%+ Owner |
STSA | Satsuma Pharmaceuticals, Inc. | Nov 21, 2022 | 1 | $107K | 4 | Nov 23, 2022 | 10%+ Owner |
ASTC | ASTROTECH Corp | Nov 16, 2022 | 3 | $145K | 4 | Nov 18, 2022 | 10%+ Owner |
STSA | Satsuma Pharmaceuticals, Inc. | Nov 14, 2022 | 3 | $4.39M | 4 | Nov 16, 2022 | 10%+ Owner |
STSA | Satsuma Pharmaceuticals, Inc. | Nov 14, 2022 | 0 | $0 | 3 | Nov 16, 2022 | 10%+ Owner |
MTCR | Metacrine, Inc. | Nov 7, 2022 | 3 | $68.1K | 4 | Nov 9, 2022 | 10%+ Owner |
MTCR | Metacrine, Inc. | Oct 27, 2022 | 2 | $317K | 4 | Oct 31, 2022 | 10%+ Owner |
IRON | Gemini Therapeutics, Inc. /DE | Oct 26, 2022 | 1 | -$47K | 4 | Oct 27, 2022 | 10%+ Owner |
MTCR | Metacrine, Inc. | Oct 24, 2022 | 3 | $443K | 4 | Oct 26, 2022 | 10%+ Owner |
MTCR | Metacrine, Inc. | Oct 24, 2022 | 0 | $0 | 3 | Oct 26, 2022 | 10%+ Owner |
ASTC | ASTROTECH Corp | Oct 14, 2022 | 2 | $81.8K | 4 | Oct 18, 2022 | 10%+ Owner |
ASTC | ASTROTECH Corp | Sep 23, 2022 | 3 | $157K | 4 | Sep 27, 2022 | 10%+ Owner |
ASTC | ASTROTECH Corp | Sep 1, 2022 | 2 | $117K | 4 | Sep 7, 2022 | 10%+ Owner |
ASTC | ASTROTECH Corp | Aug 24, 2022 | 0 | $0 | 3 | Aug 25, 2022 | 10%+ Owner |
ASTC | ASTROTECH Corp | Aug 23, 2022 | 2 | $219K | 4 | Aug 25, 2022 | 10%+ Owner |
ELVN | IMARA Inc. | Jun 16, 2022 | 1 | $92.2K | 4 | Jun 21, 2022 | 10%+ Owner |
ELVN | IMARA Inc. | Jun 3, 2022 | 2 | $38K | 4 | Jun 7, 2022 | 10%+ Owner |
RVP | RETRACTABLE TECHNOLOGIES INC | May 23, 2022 | 2 | $253K | 4 | May 25, 2022 | 10%+ Owner |
RVP | RETRACTABLE TECHNOLOGIES INC | May 17, 2022 | 3 | $535K | 4 | May 19, 2022 | 10%+ Owner |
ELVN | IMARA Inc. | May 16, 2022 | 2 | $50.4K | 4 | May 18, 2022 | 10%+ Owner |
RVP | RETRACTABLE TECHNOLOGIES INC | May 12, 2022 | 3 | $554K | 4 | May 16, 2022 | 10%+ Owner |
RVP | RETRACTABLE TECHNOLOGIES INC | May 9, 2022 | 3 | $281K | 4 | May 11, 2022 | 10%+ Owner |
RVP | RETRACTABLE TECHNOLOGIES INC | Apr 28, 2022 | 3 | $1.6M | 4 | May 2, 2022 | 10%+ Owner |
RVP | RETRACTABLE TECHNOLOGIES INC | Apr 28, 2022 | 0 | $0 | 3 | May 2, 2022 | 10%+ Owner |
ELVN | IMARA Inc. | Apr 21, 2022 | 2 | $784K | 4 | Apr 25, 2022 | 10%+ Owner |
ELVN | IMARA Inc. | Apr 21, 2022 | 0 | $0 | 3 | Apr 25, 2022 | 10%+ Owner |
IRON | Gemini Therapeutics, Inc. /DE | Apr 11, 2022 | 4 | $1.34M | 4 | Apr 13, 2022 | 10%+ Owner |
IRON | Gemini Therapeutics, Inc. /DE | Apr 11, 2022 | 0 | $0 | 3 | Apr 13, 2022 | 10%+ Owner |